Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial

CONTEXT: Pioglitazone reduces cardiovascular risk in nondiabetic patients after an ischemic stroke or transient ischemic attack (TIA) but is associated with increased risk for bone fracture. OBJECTIVE: To characterize fractures associated with pioglitazone by location, mechanism, severity, timing, a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Endocrinol Metab
Glavni autori: Viscoli, Catherine M., Inzucchi, Silvio E., Young, Lawrence H., Insogna, Karl L., Conwit, Robin, Furie, Karen L., Gorman, Mark, Kelly, Michael A., Lovejoy, Anne M., Kernan, Walter N.
Format: Artigo
Jezik:Inglês
Izdano: Endocrine Society 2016
Teme:
Clinical Research Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5460686/
https://ncbi.nlm.nih.gov/pubmed/27935736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2016-3237
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items